Healthcare - Biotechnology - NASDAQ - US
$ 0.46
2.68 %
$ 43.4 M
Market Cap
-1.35
P/E
INCOME STATEMENT
675 K
REVENUE
-20.8 M
OPERATING INCOME
-30.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Unicycive Therapeutics, Inc.
| Revenue | 675 K |
| Cost Of Revenue | 284 K |
| Gross Profit | 391 K |
| Operating Expenses | 21.4 M |
| Operating Income | -20.8 M |
| Other Expenses | 9.77 M |
| Net Income | -30.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0.7 | 1.0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.3 | 7 K | 1 K | 0 | 0 | 0 |
| Gross Profit | 0.4 | 0.9 | 1 K | 0 | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 21.4 | 19.0 | 9.0 | 2.0 | 2.0 | 1.0 |
| Selling, General and Administrative Expenses | 8.5 | 6.6 | 2.9 | 1.0 | 1.2 | 0.6 |
| Research and Development Expenses | 12.9 | 12.4 | 6.1 | 1.0 | 0.8 | 0.3 |
| Operating Income | (20.8) | (18.1) | (9.0) | (2.0) | (2.0) | (1.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 82 K | 6 K | 0.6 | 0.2 | 0.1 | 0 |
| Total Other Income | (9.8) | 6 K | (1.0) | (0.2) | (0.2) | (0.2) |
| Pre-Tax Income | (30.5) | (18.1) | (10.0) | (2.3) | (2.2) | (1.1) |
| NET INCOME | ||||||
| Tax Provision | 0 | 6 K | 0.6 | 0.2 | 0.1 | (1.0) |
| Net Income | (30.5) | (18.1) | (10.6) | (2.5) | (2.3) | (1.1) |
| EPS | 1.28 | 1.2 | 0.71 | 0.16 | 0.15 | 0.0735 |